MarketFriction

Remedium Lifecare Ltd

BSE 539561 · Trading & Distributors
₹0.26 -3.70%
BSE close2026-10-01
Market cap₹22.9 Cr.
P/E10.8

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Mar 2025Jun 2025Sep 2025
Sales264.32113.37111.06
Expenses264.78111.50103.68
Operating Profit-0.461.877.38
OPM %-0.17%1.65%6.65%
Other Income0.663.483.25
Interest1.59-0.360.19
Depreciation0.010.000.00
Profit before tax-1.405.7110.44
Tax %45.71%18.56%17.34%
Net Profit-2.054.658.62
EPS in Rs-0.020.050.10
Mar 2025
Sales405
Expenses404
Operating Profit1
OPM %0.3%
Other Income11
Interest8
Depreciation0
Profit before tax4
Tax %51%
Net Profit2
EPS in Rs0.02
Dividend Payout %0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%%%%
Compounded Profit Growth%%%%
Stock Price CAGR%-40%-86%-83%
Return on Equity%%%5%
Mar 2025Sep 2025
Equity Capital4088
Reserves417
Borrowings1,1411,088
Other Liabilities535430
Total Liabilities1,7201,623
Fixed Assets06
CWIP00
Investments00
Other Assets1,7201,617
Total Assets1,7201,623
Mar 2025
Cash from Operating Activity-1,135
Cash from Investing Activity0
Cash from Financing Activity1,136
Net Cash Flow1
Free Cash Flow-1,135
CFO/OP-90,064%
Mar 2025
Debtor Days695
Inventory Days247
Days Payable459
Cash Conversion Cycle483
Working Capital Days38
ROCE %
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters1.11%1.11%1.11%1.11%1.11%1.11%1.11%1.11%1.11%1.13%1.13%1.13%
FIIs0.00%0.04%0.08%0.04%0.04%0.00%0.00%0.00%0.00%0.00%0.00%1.70%
Public98.88%98.84%98.81%98.86%98.85%98.89%98.89%98.89%98.89%98.87%98.87%97.17%
No. of Shareholders7051,7303,9883,85915,58726,46467,40473,6371,10,4221,13,5431,14,1191,11,269

Fundamentals

Market Cap₹ 22.9 Cr.
Current Price₹ 0.26
Stock P/E10.8
Book Value₹ 1.19
ROCE%
ROE4.85 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)%
Compounded Profit Growth (TTM)%
Consolidated figures.
Ownership
Promoter holding1.13% (+0.02 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Period539561Nifty 50Difference
1 week+0.0%-2.8% +2.8 pts
1 month-10.3%-6.8% -3.6 pts
3 months-16.1%-7.6% -8.5 pts
3 years-99.8%+14.2% -113.9 pts
5 years-92.5%+27.9% -120.4 pts

Red flags

No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

No quarterly results published.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Redington Ltd31,69717.618.4 %
MMTC Ltd8,51442.38.67 %
MSTC Ltd5,02821.530.3 %
BN Agrochem Ltd1,8981114.44 %
Creative Newtech Ltd1,64622.318.8 %
Pervasive Commodities Ltd1,04922.1 %
RRP Defense Ltd843-11.1 %
Yamuna Syndicate Ltd7848.564.17 %
Shiv Aum Steels Ltd74277.98.20 %
State Trading Corporation of India Ltd64413.3%
Arvaya Healthcare Ltd600451%
SMT Engineering Ltd59624.325.4 %
HP Telecom India Ltd52820.719.9 %
Riddhi Siddhi Gluco Biols Ltd52737.22.74 %
Oswal Agro Mills Ltd4742.03 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Remedium Lifecare Ltd?

Remedium Lifecare Ltd (539561) has a market capitalisation of Rs 22.9 Cr. at the 2026-10-01 close.

What is the P/E ratio of Remedium Lifecare Ltd?

Remedium Lifecare Ltd trades at a P/E of 10.8 on trailing twelve-month profit, at the 2026-10-01 close.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03